CC(=O)c1ccc(-[n+]2cc(-c3ccc(C(C)(C)C)cc3)n3c2SCCC3)cc1.[Br-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?